Insilico Medicine
Biotechnology company that uses artificial intelligence to develop new drugs and for aging research
Visit website: https://insilico.com/
Insilico Medicine is also referenced in the following:
ARDD 2021 - 8th Aging Research and Drug Discovery Meeting
31-Aug-2021 to 03-Sep-2021
Online event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen chaired by Morten Scheibye-Knudsen, Daniela Bakula and Alex Zhavoronkov, and with many speakers.
Deep Longevity
AI to track the rate of ageing at the molecular, cellular, tissue, organ, system, physiological, and psychological levels
People at Insilico Medicine
Alex Zhavoronkov
CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation
Polina Mamoshina
Chief Scientist and Chief Operating Officer at Deep Longevity and Head of Biomarker Development at Insilico Medicine.
Insilico Medicine News
BBC reports on two different uses of AI in pharmaceutical healthcare
BBC - 17-Apr-2023
Genetika+ tests drugs against a patient's own cells; Insilico Medicine is slashing the time taken for drug discovery
Read more...Insilico Medicine series D funding to grow its pipeline and create an AI-driven robotic drug discovery laboratory
Longevity Technology - 06-Jun-2022
Big data combined with laboratory automation - the pace of drug discovery is about to take off!
Read more...Insilico raises $255M to advance human trials and AI drug discovery platform
Longevity Technology - 22-Jun-2021
New collab with Teva Pharmaceuticals to identify drug targets for various diseases
Read more...First-ever AI designed drug candidate for pulmonary fibrosis
Longevity Technology - 24-Feb-2021
Insilico's novel drug target is prepping for IND studies, expecting to start clinical studies by early 2022
Read more...Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021
More and more companies making greater and greater progress - 2021 could be an exciting year
Read more...Pharma company teams with AI to develop anti aging solutions
Longevity Technology - 15-Oct-2020
Taisho and Insilico collabs to identify novel targets for senolytic drugs
Read more...AI reduces drug discovery from years to days - and that's just the start
Singularity Hub - 23-Jul-2020
Insilico Medicine is slashing the cost of drug development
Read more...Deep Longevity investors bet on growing need for aging and longevity biomarkers
FierceBiotech - 15-Jul-2020
Biological clocks are a moving target so they'll need other researchers to corroborate their analysis
Read more...Is it possible to predict biological age with gut microbiome?
Lifespan.io (LEAF) - 19-Jun-2020
Models and anti-ageing intervention design enables new ageing clock development
Read more...Orion College ageing research receives 1 million UK pounds from Jim Mellon
Lifespan.io (LEAF) - 18-May-2020
He believes in the importance of boosting immunoresilience among elderly
Read more...Proposed strategy to protect elderly from gerolavic infections like COVID-19
Forbes - 31-Mar-2020
To benefit long term global health and longevity, and enhance economic recovery
Read more...Clinical trials now up for Exscientia's world first AI-made drug
pharmaphorum - 30-Jan-2020
Partnering with Japan's DSP, a milestone is reached in OCD treatment
Read more...Nanalyze looks at Insilico Medicine's AlphaGo moment in pharma
Nanalyze - 09-Oct-2019
From lab to clinic in 2 years instead of 10 would have a huge impact on health
Read more...Insilico and ARK enter a research collaboration on health-span and longevity
EurekAlert! - 22-May-2019
AI-based methods, to explore mechanisms of ageing and improving health-span
Read more...Gut microbiome predicts age with 4 year accuracy
Lifespan.io (LEAF) - 15-Jan-2019
It both affects and is affected by its host status
Read more...Aging focused biotechs forms AI based joint venture
FierceBiotech - 14-Aug-2018
Groundbreaking research biotechs performs aging research together for longevity
Read more...Interview with Juvenescence author Jim Mellon
Medium - 17-May-2018
Juvenescence Ltd is making investments in the future of rejuvenation and life extension technology
Read more...AgeX Identifies Genes Implicated in Regeneration and Cancer
Business Wire - 02-Jan-2018
Study that reveals genes implicated in tissue regeneration, cancer, and aging. Worked in collabo...
Read more...9 Computational Drug Discovery Startups Using AI
Nanalyze - 25-Apr-2017
Including BenevolentAI which already has 24 drug candidates. 98% of big data has only been creat...
Read more...AI Versus Aging
Lifespan.io (LEAF) - 18-Apr-2017
Interview with Dr. Alex Zhavoronkov, CEO of Insilico Medicine Company awarded the ‘Most Promisin...
Read more...Display all news
